FDA Adverse Event Injury Summary report: N

VGXP XP E1 TIB BRG LM 10X79

MDR report key: 8043283 · Received November 6, 2018

Report

Report Number
0001825034-2018-09948
Event Type
Injury
Date Received
November 6, 2018
Date of Event
September 24, 2018
Report Date
July 19, 2019
Manufacturer
ZIMMER BIOMET, INC.
Product Code
MBH
PMA / PMN Number
K132873
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED PATIENT UNDERWENT A MANIPULATION APPROXIMATELY FIVE MONTHS POST IMPLANTATION DUE TO STIFFNESS. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION HAVE BEEN MADE; HOWEVER, NO MORE IS AVAILABLE.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: VGXP XP INLK PRI TIB TRAY; P/N: 195758, L/N: 999400; BCM-PALACOS-UNK; P/N: UNK, L/N: UNK; VGXP INTLK FEMORAL; P/N: 195926, L/N: 162120; SERIES A PAT STD 34; P/N: 184766, L/N: 346140; VGXP XP E1 TIB BRG LM; P/N: 195892, L/N: 257460; VGXP XP E1 TIB BRG LL; P/N: 195822, L/N: 168570. (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, DUE TO IT REMAINS IMPLANTED. THE INVESTIGATION IS IN PROCESS AND ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2018 - 09943; 0001825034 - 2018 - 09944; 0001825034 - 2018 - 09858; 0001825034 - 2018 - 09949.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT UNDERWENT AN INITIAL LEFT KNEE ARTHROPLASTY 5 MONTHS POST IMPLANTATION. SUBSEQUENTLY, THE PATIENT UNDERWENT A MANIPULATION DUE TO STIFFNESS. NO ADDITIONAL PATIENT CONSEQUENCES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
882639 VGXP XP E1 TIB BRG LM 10X79 PROSTHESIS, KNEE MBH ZIMMER BIOMET, INC. N/A 257460

Patients

Seq Age Sex Outcome Treatment
1 51 YR Hospitalization| R